Q1 2024 Holdings
Filed 2024-05-14 | 11 holdings | $155.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvation Bio(NUVB) | Common Stock Class A | 67080N101 | $51.2M | 14,072,340 | 33.0% |
| Lexeo Therapeutics(LXEO) | Common Stock | 52886X107 | $36.9M | 2,355,904 | 23.8% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $24.5M | 3,001,319 | 15.8% |
| enGene Holdings Inc.(ENGN) | Common Stock | 29286M105 | $18.2M | 1,076,357 | 11.8% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $8.4M | 843,750 | 5.4% |
| Morphic Holding | Common Stock | 61775R105 | $5.6M | 159,846 | 3.6% |
| Ikena Oncology | Common Stock | 45175G108 | $3.2M | 2,249,123 | 2.1% |
| Immunic Inc(IMUX) | Common Stock | 4525EP101 | $2.4M | 1,788,160 | 1.5% |
| enGene Holdings Inc.(ENGNW) | Warrant | 29286M113 | $1.9M | 360,903 | 1.2% |
| Syros Pharmaceuticals(SYRS) | Common Stock | 87184Q206 | $1.3M | 251,270 | 0.9% |
| Kronos Bio(KRON1USD) | Common Stock | 50107A104 | $1.2M | 955,866 | 0.8% |